Antigen-induced immunomodulation in the pathogenesis of atherosclerosis

Clinical and Developmental Immunology

Volumn 2008, Issue , 2008, Pages

  Milioti, Natalia ^a   Bermudez Fajardo, Alexandra ^a   Penichet, Manuel L ^b   Oviedo Orta, Ernesto ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIGEN; BETA2 GLYCOPROTEIN 1; COLLAGEN; FIBRINOGEN; HEAT SHOCK PROTEIN; LIPOPROTEIN A; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADAPTIVE IMMUNITY; ANEURYSM; ARTERY CALCIFICATION; ARTERY OCCLUSION; ARTERY RUPTURE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHLAMYDOPHILA PNEUMONIAE; CHRONIC INFLAMMATION; CYTOMEGALOVIRUS; ENTEROVIRUS; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; LYMPHOCYTE; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; ANIMAL; DISEASE COURSE; IMMUNOLOGY; INFLAMMATION; LIPID METABOLISM; PATHOLOGY; T LYMPHOCYTE;

ANIMALS; ANTIGENS; ATHEROSCLEROSIS; DISEASE PROGRESSION; HUMANS; INFLAMMATION; LIPID METABOLISM; T-LYMPHOCYTES;

EID: 45349090687     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2008/723539     Document Type: Review

References (177)

1. Shashkin P.
2. Shi W., Wang X., Shih D. M., Laubach V. E., Navab M., Lusis A. J.
3. Pan J. H., Sukhova G. K., Yang J. T., Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice Circulation 2004 109 25 3149 3153
4. Lucas A. D., Greaves D. R., Atherosclerosis: role of chemokines and macrophages Expert Reviews in Molecular Medicine 2001 3 25 1 18
5. Fan J., Watanabe T., Inflammatory reactions in the pathogenesis of atherosclerosis Journal of Atherosclerosis and Thrombosis 2003 10 2 63 71
6. Michelsen K. S., Arditi M.
7. Stoll G.
8. Jonasson L., Holm J., Skalli O., Bondjers G., Hansson G. K., Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque Arteriosclerosis 1986 6 2 131 138
9. Yan Z.-Q.
10. Newby A. C.
11. Hoofnagle M. H., Thomas J. A., Wamhoff B. R., Owens G. K.
12. De Meyer G. R., Bult H., Mechanisms of neointima formation& - lessons from experimental models Vascular Medicine 1997 2 3 179 189
13. Jackson C. L.
14. Jackson C. L.
15. Hansson G. K., Libby P.
16. Pinderski L. J., Fischbein M. P., Subbanagounder G., Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes Circulation Research 2002 90 10 1064 1071
17. Dansky H. M., Charlton S. A., Harper M. M., Smith J. D.
18. Esaki T., Hayashi T., Muto E., Yamada K., Kuzuya M., Iguchi A., Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits Atherosclerosis 1997 128 1 39 46
19. Ludewig B.
20. Xu Q.
21. Hörkkö S., Binder C. J., Shaw P. X., Immunological responses to oxidized LDL Free Radical Biology and Medicine 2000 28 12 1771 1779
22. Aikawa M.
23. Leitinger N.
24. George J., Shoenfeld Y., Harats D., The involvement of β 2-glycoprotein I (β 2-GPI) in human and murine atherosclerosis Journal of Autoimmunity 1999 13 1 57 60
25. George J., Harats D., Gilburd B., Adoptive transfer of β 2-glycoprotein i-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice Circulation 2000 102 15 1822 1827
26. Jara L. J.
27. Poon M.
28. de Carvalho J. F.
29. Ge J.
30. Kol A., Lichtman A. H., Finberg R. W., Libby P., Kurt-Jones E. A.
31. Lamb D. J.
32. Sander G. E., Giles T. D., Cardiovascular complications of collagen vascular disease Current Treatment Options in Cardiovascular Medicine 2002 4 2 151 159
33. Amento E. P., Ehsani N., Palmer H., Libby P., Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells Arteriosclerosis and Thrombosis 1991 11 5 1223 1230
34. Thomas A. H., Edelman E. R., Stultz C. M.
35. Temelkova-Kurktschiev T.
36. Hajishengallis G., Sharma A., Russell M. W., Genco R. J., Interactions of oral pathogens with Toll-like receptors: possible role in atherosclerosis Annals of Periodontology 2002 7 1 72 78
37. Yumoto H., Chou H.-H., Takahashi Y., Davey M., Gibson F. C. III, Genco C. A.
38. Byrne G. I., Kalayoglu M. V., Chlamydia pneumoniae and atherosclerosis: links to the disease process American Heart Journal 1999 138 5, supplement 1 S488 S490
39. Jha H. C.
40. Ciervo A.
41. Gagliardi R. J.
42. Ezzahiri R.
43. Yoshida T.
44. Yavuz M. T.
45. Wang S. S., Tondella M. L. C., Bajpai A., Circulating Chlamydia pneumoniae DNA and advanced coronary artery disease International Journal of Cardiology 2007 118 2 215 219
46. Hauer A. D.
47. Poppert S.
48. Nazzal D., Cantéro A.-V., Therville N., Chlamydia pneumoniae alters mildly oxidized low-density lipoprotein-induced cell death in human endothelial cells, leading to necrosis rather than apoptosis The Journal of Infectious Diseases 2006 193 1 136 145
49. Sessa R.
50. Nakano K., Inaba H., Nomura R., Detection of cariogenic Streptococcus mutans in extirpated heart valve and atheromatous plaque specimens Journal of Clinical Microbiology 2006 44 9 3313 3317
51. Franceschi F., Sepulveda A. R., Gasbarrini A., Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis Circulation 2002 106 4 430 434
52. Kowalski M., Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific dna in human coronary atherosclerotic plaque Journal of Physiology and Pharmacology 2001 52 1, supplement 1 3 31
53. Farsak B., Yildirir A., Akyön Y., Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR Journal of Clinical Microbiology 2000 38 12 4408 4411
54. Okada T., Ayada K., Usui S., Antibodies against heat shock protein 60 derived from Helicobacter pylori: diagnostic implications in cardiovascular disease Journal of Autoimmunity 2007 29 2-3 106 115
55. Kilic A.
56. Adiloglu A. K.
57. Park M. H., Min J. Y., Koh S. B., Helicobacter pylori infection and the CD14 C(-260)T gene polymorphism in ischemic stroke Thrombosis Research 2006 118 6 671 677
58. Cassar K.
59. Mach F., Sukhova G. K., Michetti M., Libby P., Michetti P., Influence of Helicobacter pylori infection during atherogenesis in vivo in mice Circulation Research 2002 90 1 E1 E4
60. Markus H. S., Risley P., Mendall M. A., Steinmetz H., Sitzer M., Helicobacter pylori infection, the cytotoxin gene A strain, and carotid artery intima-media thickness Journal of Cardiovascular Risk 2002 9 1 1 6
61. Rechciński T., Kasprzak J. D., Chmiela M., Krzemińska- pakuła M., Rudnicka W., Patients with unstable angina pectoris present increased humoral response against Helicobacter pylori in comparison with patients with aggravated dyspepsia Acta Microbiologica Polonica 2002 51 4 339 344
62. Folsom A. R.
63. Cammarota G., Pasceri V., Papa A., Helicobacter pylori infection and ischaemic heart disease Italian Journal of Gastroenterology and Hepatology 1998 30 supplement 3 S304 S306
64. Ossei-Gerning N., Moayyedi P., Smith S., Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography Cardiovascular Research 1997 35 1 120 124
65. Mayr M., Metzler B., Kiechl S., Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis Circulation 1999 99 12 1560 1566
66. Ünlü A., Türközkan N., Cimen B., Karabicak U., Yaman H., The effect of Escherichia coli -derived lipopolysaccharides on plasma levels of malondialdehyde and 3-nitrotyrosine Clinical Chemistry and Laboratory Medicine 2001 39 6 491 493
67. Roivainen M., Alfthan G., Jousilahti P., Kimpimäki M., Hovi T., Tuomilehto J.
68. Kwon T. W., Kim D. K., Ye J. S., Detection of enterovirus, cytomegalovirus, and Chlamydia pneumoniae in atheromas Journal of Microbiology 2004 42 4 299 304
69. Cainelli F.
70. Frostegard J., Nilsson J., Haegerstrand A., Hamsten A., Wigzell H., Gidlund M., Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937 Proceedings of the National Academy of Sciences of the United States of America 1990 87 3 904 908
71. Gredmark S., Jonasson L., Van Gosliga D., Ernerudh J., Söderberg-Nauclér C., Active cytomegalovirus replication in patients with coronary disease Scandinavian Cardiovascular Journal 2007 41 4 230 234
72. Grahame-Clarke C.
73. Vliegen I.
74. Altannavch Ts.
75. Taylor-Robinson D., Thomas B. J., Antibodies to cytomegalovirus or Chlamydia pneumoniae and coronary heart disease The Lancet 1998 351 9096 143
76. Adam E., Melnick J. L., DeBakey M. E., Cytomegalovirus infection and atherosclerosis Central European Journal of Public Health 1997 5 3 99 106
77. Zhou Y. F., Guetta E., Yu Z. X., Finkel T., Epstein S. E., Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells Journal of Clinical Investigation 1996 98 9 2129 2138
78. Koskinen P., Lemstrøm K., Mattila S., Häyry P., Nieminen M. S., Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft Clinical Transplantation 1996 10 6 487 493
79. Puskás L. G.
80. Olofsson S.-O.
81. Groyer É., Caligiuri G., Laschet-Khallou J., Nicoletti A.
82. Hammer A., Kager G., Dohr G., Rabl H., Ghassempur I., Jürgens G., Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins Arteriosclerosis, Thrombosis, and Vascular Biology 1995 15 5 704 713
83. Festa A., Kopp H. P., Schernthaner G., Menzel E. J., Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications Diabetologia 1998 41 3 350 356
84. Iuliano L., Signore A., Violi F., Uptake of oxidized LDL by human atherosclerotic plaque Circulation 1997 96 6 2093 2094
85. Yla-Herttuala S.
86. Olsson U.
87. Olofsson S.-O.
88. Steinberg D., Carew T. E., Fielding C., Lipoproteins and the pathogenesis of atherosclerosis Circulation 1989 80 3 719 723
89. Itabe H.
90. Rahaman S. O., Lennon D. J., Febbraio M., Podrez E. A., Hazen S. L., Silverstein R. L.
91. Lim H.-J., Lee S., Lee K.-S., PPARγ activation induces CD36 expression and stimulates foam cell like changes in rVSMCs Prostaglandins & Other Lipid Mediators 2006 80 3-4 165 174
92. Wintergerst E. S., Jelk J., Asmis R., Differential expression of CD14, CD36 and the LDL receptor on human monocyte-derived macrophages: a novel cell culture system to study macrophage differentiation and heterogeneity Histochemistry and Cell Biology 1998 110 3 231 241
93. Ruiz-Velasco N., Domínguez A., Vega M. A.
94. Kaplan M., Aviram M.
95. Binder C. J.
96. Holvoet P., Perez G., Zhao Z., Brouwers E., Bernar H., Collen D., Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease Journal of Clinical Investigation 1995 95 6 2611 2619
97. Lecomte E., Artur Y., Chancerelle Y., Malondialdehyde adducts to, and fragmentation of, apolipoprotein B from human plasma Clinica Chimica Acta 1993 218 1 39 46
98. Choudhury R. P.
99. Moore K. J.
100. Bobryshev Y. V.
101. Miller Y. I.
102. Pasini A. F., Anselmi M., Garbin U., Enhanced levels of oxidized low-density lipoprotein prime monocytes to cytokine overproduction via upregulation of CD14 and Toll-like receptor 4 in unstable angina Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 9 1991 1997
103. Yang Q. W.
104. Libby P.
105. Caligiuri G.
106. Shaw P. X.
107. Palinski W., Miller E., Witztum J. L., Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis Proceedings of the National Academy of Sciences of the United States of America 1995 92 3 821 825
108. Nilsson J., Calara F., Regnstrom J., Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits Journal of the American College of Cardiology 1997 30 7 1886 1891
109. George J., Afek A., Gilburd B., Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis Atherosclerosis 1998 138 1 147 152
110. Freigang S., Hörkkö S., Miller E., Witztum J. L., Palinski W.
111. Zhou X., Caligiuri G., Hamsten A., Lefvert A. K., Hansson G. K.
112. Reichlin M.
113. Mamputu J. C., Desfaits A. C., Renier G., Lipoprotein lipase enhances human monocyte adhesion to aortic endothelial cells Journal of Lipid Research 1997 38 9 1722 1729
114. Basta G., Schmidt A. M., De Caterina R.
115. Sun M., Yokoyama M., Ishiwata T., Asano G., Deposition of advanced glycation end products (AGE) and expression of the receptor for AGE in cardiovascular tissue of the diabetic rat International Journal of Experimental Pathology 1998 79 4 207 222
116. Miyazaki A.
117. Tlaskalová-Hogenová H.
118. Hollestelle S. C. G., de Vries M. R., van Keulen J. K., Toll-like receptor 4 is involved in outward arterial remodeling Circulation 2004 109 3 393 398
119. de Graaf R.
120. Triantafilou M., Gamper F. G. J., Lepper P. M., Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells Cellular Microbiology 2007 9 8 2030 2039
121. Ford P. J.
122. Söder B.
123. Ieven M., Chlamydia pneumoniae and atherosclerosis Verhandelingen& - Koninklijke Academie voor Geneeskunde van Belgie 2001 63 5 433 445. discussion 446
124. Kaklikkaya I.
125. Bobryshev Y. V.
126. Belland R. J.
127. Sessa R.
128. Mussa F. F., Chai H., Wang X., Yao Q., Lumsden A. B., Chen C.
129. de Kruif M. D.
130. Su H., Caldwell H. D., CD4 + T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract Infection and Immunity 1995 63 9 3302 3308
131. Morrison S. G., Morrison R. P., Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells Infection and Immunity 2001 69 4 2643 2649
132. Brunham R. C.
133. Entrican G., Buxton D., Longbottom D., Chlamydial infection in sheep: immune control versus fetal pathology Journal of the Royal Society of Medicine 2001 94 6 273 277
134. Kuppuswamy V. C., Gupta S., Antibiotic therapy for coronary heart disease: the myth and the reality Timely Topics in Medicine. Cardiovascular Diseases 2006 10 E2
135. Riganò R.
136. Hauet-Broere F., Wieten L., Guichelaar T., Berlo S., van der Zee R., Van Eden W.
137. Ford P. J.
138. Liu R., Moroi M., Yamamoto M., Presence and severity of Chlamydia pneumoniae and cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes International Heart Journal 2006 47 4 511 519
139. Virok D., Kis Z., Kari L., Chlamydophila pneumoniae and human cytomegalovirus in atherosclerotic carotid plaques& - combined presence and possible interactions Acta Microbiologica et Immunologica Hungarica 2006 53 1 35 50
140. Westphal M., Lautenschlager I., Backhaus C., Cytomegalovirus and proliferative signals in the vascular wall of CABG patients Thoracic and Cardiovascular Surgeon 2006 54 4 219 226
141. Müller B. T.
142. Sun Y., Pei W., Welte T., Wu Y., Ye S., Yang Y.
143. Bason C., Corrocher R., Lunardi C.
144. Olofsson P. S., Jatta K., Wågsäter D., The antiviral cytomegalovirus inducible gene 5/viperin is expressed in atherosclerosis and regulated by proinflammatory agents Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 7 e113 e116
145. Fairweather D., Frisancho-Kiss S., Rose N. R.
146. Melnick J. L., Adam E., DeBakey M. E., Cytomegalovirus and atherosclerosis Archivum Immunologiae et Therapiae Experimentalis 1996 44 5-6 297 302
147. Ibrahim A. I., Obeid M. T., Jouma M. J., Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts Journal of Clinical Virology 2005 32 1 29 32
148. Scheglovitova O. N., Romanov Y. A., Maksianina E. V., Svintsitskaya V. A., Pronin A. G., Herpes simplex type I virus infected human vascular endothelial cells induce the production of anti-viral and proinflammatory factors by peripheral blood leukocytes in vitro Russian Journal of Immunology 2002 7 2 115 122
149. Shi Y.
150. Kotronias D., Kapranos N.
151. Stemme S., Faber B., Holm J., Wiklund O., Witztum J. L., Hansson G. K., T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein Proceedings of the National Academy of Sciences of the United States of America 1995 92 9 3893 3897
152. Nilsson J.
153. Szodoray P.
154. Mallat Z.
155. Laurat E., Poirier B., Tupin E., In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice Circulation 2001 104 2 197 202
156. Fredrikson G. N.
157. Frederikson G. N.
158. Nilsson J.
159. Fredrikson G. N.
160. Caligiuri G., Nicoletti A., Poirier B., Hansson G. K.
161. Palinski W.
162. Binder C. J., Hörkkö S., Dewan A., Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL Nature Medicine 2003 9 6 736 743
163. Kobayashi K., Tada K., Itabe H., Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages Lupus 2007 16 12 929 938
164. Shaw P. X., Hörkkö S., Chang M.-K., Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity Journal of Clinical Investigation 2000 105 12 1731 1740
165. Paigen B., Morrow A., Brandon C., Mitchell D., Holmes P., Variation in susceptibility to atherosclerosis among inbred strains of mice Atherosclerosis 1985 57 1 65 73
166. Huber S. A.
167. Whitman S. C., Ravisankar P., Elam H., Daugherty A., Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/- mice American Journal of Pathology 2000 157 6 1819 1824
168. Liu Y., Li D., Chen J., Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10 Atherosclerosis 2006 188 1 19 27
169. Pinderski Oslund L. J.
170. Buono C., Binder C. J., Stavrakis G., Witztum J. L., Glimcher L. H., Lichtman A. H.
171. Cheng X., Yu X., Ding Y., The Th17/Treg imbalance in patients with acute coronary syndrome Clinical Immunology 2008 127 1 89 97
172. Bi Y., Liu G.
173. Afzali B., Lombardi G., Lechler R. I., Lord G. M.
174. Stockinger B.
175. Schmidt-Weber C. B.
176. Bettelli E., Korn T., Kuchroo V. K.
177. Weaver C. T.